RIGL
HEALTHCARERigel Pharmaceuticals
$26.67-1.42 (-5.06%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving RIGL Today?
No stock-specific AI insight has been generated for RIGL yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$17.64$52.24
$26.67
Fundamentals
Market Cap$493M
P/E Ratio1.4
EPS$19.48
Dividend Yield—
Dividend / Share—
ROE1.9%
Profit Margin1.2%
Debt / Equity—
Trading
Volume850K
Avg Volume (10D)—
Shares Outstanding18.5M
RIGL News
20 articles- This Fund Cashed Out of Preformed Line Products Amid a 150% Stock SurgeMotley Fool·May 8, 2026
- Rigel Pharmaceuticals, Inc. Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- Rigel Pharmaceuticals Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue EstimatesYahoo Finance·May 5, 2026
- Rigel Reports First Quarter 2026 Financial ResultsYahoo Finance·May 5, 2026
- Rigel Pharmaceuticals (RIGL) to Report Q1 Results: Wall Street Expects Earnings GrowthYahoo Finance·Apr 28, 2026
- Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial ResultsYahoo Finance·Apr 28, 2026
- Is the Options Market Predicting a Spike in Rigel Pharmaceuticals Stock?Yahoo Finance·Apr 24, 2026
- Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)Yahoo Finance·Apr 7, 2026
- Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical OncologyYahoo Finance·Mar 31, 2026
- Jim Cramer Blesses Rigel Pharmaceuticals as a Spec as “It’s Doing Better Than People Realize”Yahoo Finance·Mar 27, 2026
- Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?Yahoo Finance·Mar 27, 2026
- Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer DataMotley Fool·Mar 16, 2026
- Rigel Pharmaceuticals Inc (RIGL) Q4 2025 Earnings Call Highlights: Record Net Income and ...Yahoo Finance·Mar 4, 2026
- How The Rigel Pharmaceuticals (RIGL) Story Is Shifting With New Targets And Pipeline ProgressYahoo Finance·Mar 4, 2026
- Rigel Pharma (RIGL) Earnings Call TranscriptMotley Fool·Mar 3, 2026
- Rigel Pharmaceuticals Q4 Earnings Call HighlightsMarketbeat·Mar 3, 2026
- Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss EstimatesYahoo Finance·Mar 3, 2026
- Rigel: Q4 Earnings SnapshotYahoo Finance·Mar 3, 2026
- Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateYahoo Finance·Mar 3, 2026
All 20 articles loaded
Price Data
Open$29.01
Previous Close$28.09
Day High$29.59
Day Low$28.79
52 Week High$52.24
52 Week Low$17.64
52-Week Range
$17.64$52.24
$26.67
Fundamentals
Market Cap$493M
P/E Ratio1.4
EPS$19.48
Dividend Yield—
Dividend / Share—
ROE1.9%
Profit Margin1.2%
Debt / Equity—
Trading
Volume850K
Avg Volume (10D)—
Shares Outstanding18.5M
About Rigel Pharmaceuticals
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat blood disorders, cancer, and rare immune diseases. The company is headquartered in South San Francisco, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—